Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022-2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts

Overview

Journal Viruses

Publisher MDPI

Date 2025 Jan 25

PMID 39861853

Authors

Ueric Jose Borges de Souza

Fernando Rosado Spilki

Amilcar Tanuri

Paulo Michel Roehe

Fabricio Souza Campos

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2, the virus responsible for COVID-19, has undergone significant genetic evolution since its emergence in 2019. This study examines the genomic diversity of SARS-CoV-2 in Brazil after the worst phase of the pandemic, the wider adoption of routine vaccination, and the abolishment of other non-pharmacological preventive measures from July 2022 to July 2024 using 55,951 sequences retrieved from the GISAID database. The analysis focuses on the correlation between confirmed COVID-19 cases, sequencing efforts across Brazilian states, and the distribution and evolution of viral lineages. Our findings reveal significant regional disparities in genomic surveillance, with São Paulo and Rio de Janeiro recovering the largest number of genomes, while Tocantins and Amazonas showed higher sequencing rates relative to their reported case numbers, indicating proactive surveillance efforts. We identified 626 distinct SARS-CoV-2 lineages circulating in Brazil, with dominant subvariants shifting over time from BA.5 in 2022 to XBB and JN.1 in 2023-2024. The emergence of new subvariants in this new epidemiological scenario underscores the importance of ongoing genomic surveillance to track viral evolution and inform public health strategies, providing valuable information to update vaccines and implement other measures, such as lockdowns, mask usage, social distancing, health education, and self-testing.

References

Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M . Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion. Nat Commun. 2024; 15(1):2254. PMC: 10938001. DOI: 10.1038/s41467-024-46490-7. View

Amicone M, Borges V, Alves M, Isidro J, Ze-Ze L, Duarte S . Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution. Evol Med Public Health. 2022; 10(1):142-155. PMC: 8996265. DOI: 10.1093/emph/eoac010. View

McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

Mistry P, Barmania F, Mellet J, Peta K, Strydom A, Viljoen I . SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front Immunol. 2022; 12:809244. PMC: 8761766. DOI: 10.3389/fimmu.2021.809244. View

Moreira F, Bonfim D, Zauli D, Silva J, Lima A, Malta F . Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil. Viruses. 2021; 13(6). PMC: 8230136. DOI: 10.3390/v13060984. View

Arantes I, Gomes M, Ito K, Sarafim S, Graf T, Miyajima F . Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023. Microbiol Spectr. 2024; 12(3):e0383123. PMC: 10913747. DOI: 10.1128/spectrum.03831-23. View

Candido D, Claro I, de Jesus J, Souza W, Moreira F, Dellicour S . Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369(6508):1255-1260. PMC: 7402630. DOI: 10.1126/science.abd2161. View

Markov P, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis N . The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023; 21(6):361-379. DOI: 10.1038/s41579-023-00878-2. View

Souza U, Dos Santos R, de Melo F, Belmok A, Galvao J, de Rezende T . Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil. Viruses. 2022; 14(4). PMC: 9031820. DOI: 10.3390/v14040659. View

10.

Petrova V, Russell C . The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2017; 16(1):60. DOI: 10.1038/nrmicro.2017.146. View

11.

Rawson J, Landman S, Reilly C, Mansky L . HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 2015; 12:60. PMC: 4496919. DOI: 10.1186/s12977-015-0180-6. View

12.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

13.

Abavisani M, Rahimian K, Mahdavi B, Tokhanbigli S, Mollapour Siasakht M, Farhadi A . Mutations in SARS-CoV-2 structural proteins: a global analysis. Virol J. 2022; 19(1):220. PMC: 9759450. DOI: 10.1186/s12985-022-01951-7. View

14.

Menezes D, Fonseca P, de Araujo J, de Souza R . SARS-CoV-2 Genomic Surveillance in Brazil: A Systematic Review with Scientometric Analysis. Viruses. 2022; 14(12). PMC: 9784312. DOI: 10.3390/v14122715. View

15.

Brito A, Semenova E, Dudas G, W Hassler G, Kalinich C, Kraemer M . Global disparities in SARS-CoV-2 genomic surveillance. Nat Commun. 2022; 13(1):7003. PMC: 9667854. DOI: 10.1038/s41467-022-33713-y. View

16.

Ribeiro R, Li H, Wang S, Stoddard M, Learn G, Korber B . Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog. 2012; 8(8):e1002881. PMC: 3426522. DOI: 10.1371/journal.ppat.1002881. View

17.

Volz E, Hill V, McCrone J, Price A, Jorgensen D, OToole A . Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell. 2020; 184(1):64-75.e11. PMC: 7674007. DOI: 10.1016/j.cell.2020.11.020. View

18.

Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

19.

Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J . Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021; 592(7854):438-443. DOI: 10.1038/s41586-021-03402-9. View

20.

Araf Y, Akter F, Tang Y, Fatemi R, Parvez M, Zheng C . Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022; 94(5):1825-1832. PMC: 9015557. DOI: 10.1002/jmv.27588. View